DEF 14A FOR ELITE PHARMACEUTICALS

Company

ELITE PHARMACEUTICALS INC /NV/

Filed

September 13, 2001

Period of Report

October 11, 2001

Accession Number

0001021408-01-506601

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →